TD Waterhouse Canada’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.76K | Hold |
6,000
| – | – | ﹤0.01% | 1485 |
|
|
2025
Q1 | $15.2K | Hold |
6,000
| – | – | ﹤0.01% | 1317 |
|
|
2024
Q4 | $11.1K | Hold |
6,000
| – | – | ﹤0.01% | 1388 |
|
|
2024
Q3 | $6.24K | Hold |
6,000
| – | – | ﹤0.01% | 1442 |
|
|
2024
Q2 | $6.84K | Hold |
6,000
| – | – | ﹤0.01% | 1424 |
|
|
2024
Q1 | $7.44K | Hold |
6,000
| – | – | ﹤0.01% | 1431 |
|
|
2023
Q4 | $10.4K | Hold |
6,000
| – | – | ﹤0.01% | 1244 |
|
|
2023
Q3 | $9.42K | Hold |
6,000
| – | – | ﹤0.01% | 1244 |
|
|
2023
Q2 | $10.9K | Hold |
6,000
| – | – | ﹤0.01% | 1227 |
|
|
2023
Q1 | $13.2K | Hold |
6,000
| – | – | ﹤0.01% | 1165 |
|
|
2022
Q4 | $8.16K | Hold |
6,000
| – | – | ﹤0.01% | 1250 |
|
|
2022
Q3 | $6.3K | Hold |
6,000
| – | – | ﹤0.01% | 1314 |
|
|
2022
Q2 | $6.48K | Hold |
6,000
| – | – | ﹤0.01% | 1333 |
|
|
2022
Q1 | $6.24K | Hold |
6,000
| – | – | ﹤0.01% | 1419 |
|
|
2021
Q4 | $5.76K | Buy |
+6,000
| New | +$5.76K | ﹤0.01% | 1432 |
|